Actively Recruiting
Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
Led by Centre Hospitalier de Gonesse · Updated on 2025-07-16
152
Participants Needed
1
Research Sites
39 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.
CONDITIONS
Official Title
Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Confirmed acute ischemic stroke on imaging
- Treated with both thrombolysis and thrombectomy
- Clinical follow-up data available at 90 days (mRS score)
You will not qualify if you...
- Primary hemorrhagic stroke
- Early death or loss to follow-up without evaluation
- Poor-quality imaging that cannot be analyzed
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier de Gonesse
Gonesse, France
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here